Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:temple
|
| gptkbp:acquisition |
gptkb:Med_Immune
gptkb:Alexion_Pharmaceuticals |
| gptkbp:clinical_trial |
COVID-19 vaccine trials
oncology trials respiratory trials |
| gptkbp:collaborations |
gptkb:University_of_Toronto
gptkb:Mc_Master_University |
| gptkbp:employees |
over 1,000
|
| gptkbp:focus |
research and development
|
| gptkbp:founded |
gptkb:2000
|
| gptkbp:headquarters |
gptkb:Mississauga,_Ontario,_Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Astra Zeneca Canada Inc.
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:parent_company |
gptkb:Astra_Zeneca_PLC
|
| gptkbp:part_of |
gptkb:Astra_Zeneca_Group
|
| gptkbp:products |
vaccines
oncology drugs cardiovascular drugs respiratory drugs |
| gptkbp:sustainability_initiatives |
gptkb:healthcare_access
community engagement environmental responsibility |
| gptkbp:website |
www.astrazeneca.ca
|